TY - JOUR
T1 - Expansion of the Genotypic and Phenotypic Spectrum of SETD5 Disorder Using Data From the National Brain Gene Registry
AU - Brain Gene Registry Consortium
AU - PRO Payne
AU - Callahan, Nora C.
AU - Mahida, Sonal
AU - Sveden, Abigail
AU - Quinn, Meg
AU - Chopra, Maya
AU - Srivastava, Siddharth
AU - Wasserstein, M.
AU - Chopra, M.
AU - Sahin, M.
AU - Wangler, M.
AU - Schultz, B.
AU - Izumi, K.
AU - Gropman, A.
AU - Smith-Hicks, C.
AU - Abbeduto, L.
AU - Hazlett, H.
AU - German, K.
AU - DaWalt, L.
AU - Neul, J.
AU - Constantino, J.
AU - Gurnett, C.
AU - Baldridge, D.
AU - Srivastava, S.
AU - Molholm, S.
AU - Walkley, S.
AU - Storch, E.
AU - Samaco, R.
AU - Cohen, J.
AU - Shankar, S.
AU - Piven, J.
AU - Berger, S.
AU - Mahida, S.
AU - Sveden, A.
AU - Dies, K.
AU - Riggs, E. R.
AU - Savatt, J. M.
AU - Lanzotti, V.
AU - Oh, I.
AU - Gupta, A.
AU - Minor, B.
N1 - Publisher Copyright:
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2025/9
Y1 - 2025/9
N2 - Haploinsufficiency of SETD5, which facilitates gene transcription and histone modification, causes intellectual disability. However, the full phenotypic spectrum of SETD5 Disorder is not well characterized. We summarized clinical features of participants with SETD5 Disorder enrolled in the National Brain Gene Registry (BGR). We analyzed data from 13 individuals with a molecular diagnosis of SETD5 Disorder, ages 2–37 years, using data from electronic health records, standardized surveys, and direct assessments. We also determined the number of participants for whom 10 pre-selected clinical features were present based on ICD-10 billing codes in comparison to manual review of clinical documentation. In the cohort, there were 11 unique pathogenic/likely pathogenic variants in 13 individuals from 11 different families. Of these 11 unique variants, 6 were nonsense, 4 were frameshift, and one was splice site. Participants in our cohort had features not previously reported, including brain and musculoskeletal abnormalities. One participant had cerebral palsy. For the 10 pre-selected clinical features, we showed satisfactory representation of these features by ICD-10 billing codes. This report highlights novel genotype and phenotype associations with SETD5 Disorder. Examination of larger patient cohorts with SETD5 Disorder is needed to evaluate the true prevalence of these medical conditions in this disorder.
AB - Haploinsufficiency of SETD5, which facilitates gene transcription and histone modification, causes intellectual disability. However, the full phenotypic spectrum of SETD5 Disorder is not well characterized. We summarized clinical features of participants with SETD5 Disorder enrolled in the National Brain Gene Registry (BGR). We analyzed data from 13 individuals with a molecular diagnosis of SETD5 Disorder, ages 2–37 years, using data from electronic health records, standardized surveys, and direct assessments. We also determined the number of participants for whom 10 pre-selected clinical features were present based on ICD-10 billing codes in comparison to manual review of clinical documentation. In the cohort, there were 11 unique pathogenic/likely pathogenic variants in 13 individuals from 11 different families. Of these 11 unique variants, 6 were nonsense, 4 were frameshift, and one was splice site. Participants in our cohort had features not previously reported, including brain and musculoskeletal abnormalities. One participant had cerebral palsy. For the 10 pre-selected clinical features, we showed satisfactory representation of these features by ICD-10 billing codes. This report highlights novel genotype and phenotype associations with SETD5 Disorder. Examination of larger patient cohorts with SETD5 Disorder is needed to evaluate the true prevalence of these medical conditions in this disorder.
KW - SETD5
KW - autism
KW - genotypic expansion
KW - intellectual disability
KW - phenotypic expansion
UR - https://www.scopus.com/pages/publications/105003415499
U2 - 10.1111/cge.14746
DO - 10.1111/cge.14746
M3 - Article
C2 - 40265665
AN - SCOPUS:105003415499
SN - 0009-9163
VL - 108
SP - 279
EP - 291
JO - Clinical Genetics
JF - Clinical Genetics
IS - 3
ER -